Notre actualité

Aanastra Inc and Divincell SAS will be presenting  “the PEP-NP : Peptide-based Nanoparticle platform for Targeted delivery functional mRNAs and in vivo CAR-T generation” at the 5th mRNA Based Therapeutics Summit Europe in Berlin. January 28-30,...

Aanastra Inc and Divincell  to highlight its technology in Multiple Presentations at the Advancing Gene and Cell Therapies for Cancer Conference, Philadelphia. October 15-16, 2025

Aanastra Inc and Divincell Announce Presentations of Preclinical Data at Upcoming Conferences in Support of its Lead Programs for Anti-CD19 In Vivo CAR-T (AAN-14x) and In vivo Rescue of P53 Mutations in Tumors (AAN-53x). October 14, 2025

Aanastra Inc/DIVINCELL present their” Peptide-based Nanoparticle platform for Extrahepatic Targeted delivery of Functional mRNAs “ at the 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit in Boston, June 26-28th, 2025. https://ter.li/u0m95x

Aanastra Inc/DIVINCELL present Peptide-based Nanoparticle platform for Targeted delivery at the 2nd Peptide Formulation & Delivery Innovation Summit in Boston, June 25-26th, 2025.https://ter.li/xoov9x

Aanastra Inc and Divincell present preclinical data on its p53 tumor suppressor rescue and its in vivo anti-CD19 CART programs at the 28th Annual Meeting of the American Society for Gene and Cell Therapy (ASGC). May 13-17, 2025, in New Orleans. https://lnkd.in/dHgkVjV

Aanastra Inc and DivIncell present preclinical data on its in vivo anti-CD19 CART program at the AACR Annual Meeting, Chicago, April 25-30, 2025 

Aanastra Inc and Divincell SAS present a “Peptide-based nanoparticle platform for extrahepatic targeted delivery of mRNA and gene editing” at the 4th mRNA Based Therapeutics Summit Europe, Frankfurt. January 28-30, 2025 

Aanastra Inc and Divincell SAS present a “A new Peptide nanoparticle platform for extrahepatic targeted delivery of therapeutic mRNAs” and “mRNA delivery for Factor VIII rescue in hemophilia and gene editing of PCSK9 for cholesterol lowering” at the 31st European...

Aanastra Inc and Divincell to Showcase its Peptide-RNA Therapeutics Technology in Multiple Presentations at the American Society for Gene and Cell Therapies (ASGCT) Annual Meeting 2024, Baltimore. May 07-11, 2024

Aanastra Inc and Divincell to Present Multiple Posters on RNA Therapeutics at the American Association for Cancer Research (AACR) Annual Meeting, San Diego. April 05-10, 2024